bit.bio launches custom disease model cells
Cell coding company bit.bio has launched a new disease model cell offering enabling scientists to commission disease-relevant mutation of interest. The company’s new Custom ioDisease Model Cells offering lets scientists choose the disease-relevant mutation they’re interested in. The disease-relevant mutation is engineered into bit.bio’s human ioWild Type … Read More